How Work Gets Done
Every recent leadership posting on Omada's hiring board — Chief Revenue Officer, Principal Applied Machine Learning Scientist, Senior Director of Clinical Quality, Senior Director of Clinical and Translational Research, VP of Investor Relations, VP of Commercial Operations — lists "Remote, USA" as the location. That consistency across clinical, commercial, technical, and finance leadership signals a company built around distributed work from the top down.
The seniority of those openings is reflected in the compensation data. The board's salary data across 29 salaried roles shows a median base pay of $224,000, with a spread from $154,000 to $305,000. Every listed position sits at director level or above.
| Role | Base Salary Range |
|---|---|
| Chief Revenue Officer | $400,000–$445,000 |
| Principal Applied ML Scientist | $270,480–$338,100 |
| Senior Director, Clinical Quality | $243,800–$307,750 |
| Senior Director, Clinical and Translational Research | $243,800–$304,800 |
| VP, Investor Relations and Capital Markets | $243,200–$304,000 |
| VP, Commercial Operations | $243,200–$304,000 |
The role mix shows clinical and research leadership alongside commercial operations and investor relations at similar compensation tiers. The Principal Applied ML Scientist role sits at a level indicating a senior data science function.
What the board data does not show is the daily rhythm beneath those titles. No public sprint cycles, documented decision frameworks, meeting cadences, or escalation paths appear in the research. The company's careers page emphasizes mission and values language, but values pages are aspirational by design.
The gap between what the board proves (remote-first, senior-heavy, clinically grounded) and what the public record reveals (little on daily tempo, decision rights, or cross-functional friction) is the actual story. Omada's structure is visible in its org chart; its workflow is not.
The Operating Principles
Omada's public messaging centers on three interlocking commitments: value-based reimbursement, virtual-first delivery, and human-centered technology. The founder, speaking on the record in a 2021 Healthcare IT Today interview, framed the business model explicitly against fee-for-service medicine: "We've never from day one built fee for service. It's always been on this different sort of fee structure that gives us freedom on how we render our care."
The "virtual-first" label carries a specific operational meaning at Omada. The founder described it as a discipline: "Every year you should be asking yourself how do you deliver more care services more conveniently and effectively from afar... bit by bit you'll find the thresholds and that'll push more and more care utilization into the pocket, into the home, into the cloud." This is a care-model constraint that forces the organization to justify every in-person touchpoint. The same interview positioned the company as "extremely complementary to existing in-person gear" — an adjunct to primary care, not a replacement: "Think of us as an adjunct to a primary care office or a primary care physician."
Where those principles meet the care model is in the division of labor between humans and software. The founder rejected the narrative that AI displaces clinicians: "There's a reason that artificial intelligence is a buzzword but artificial empathy is not. In an ideal world digital care feels more human — you're like, wait a second, for the first time this person is actually getting to know me on my terms." He argued that AI should "take away the mundane that humans don't want to do" and cited retention as the proof: "That's actually how you retain the best people because the best people don't want to do the mundane."
The company's programs reflect this: connected devices (scales, blood pressure cuffs, continuous glucose monitors) stream data automatically into the platform, while certified diabetes educators and licensed physical therapists provide clinical judgment and coaching. The website describes "pairs you with a care team," "proactive and compassionate" coaches, "weekly interactive lessons" covering "physical, social, and psychological components," and "an online community of peers." The MSK acquisition (Fizera, now Omada for Joint & Muscle Health) extended the model into physical therapy with "unlimited video visits and messages with a licensed physical therapist" and an exercise kit shipped to the member's home. Pricing transparency appears in practice: Prevention, Diabetes, and Hypertension programs are "offered at no cost to you" through employers and health plans, while the MSK program discloses standard cost-sharing.
External reporting on how these values translate into employee experience is thin. The research corpus contains no independent journalism, Glassdoor analyses, or employee-authored accounts beyond the founder's interviews and the company's marketing pages. The board data shows senior roles priced at $240,000–$445,000, consistent with a company competing for experienced clinical and commercial talent, but it does not illuminate day-to-day culture.
What the Hiring Bar Selects For
Omada does not publish a public hiring rubric. What the market can observe comes from the roles the company chooses to open, the seniority of those openings, and the compensation bands detailed above.
The profile indicates Omada hires for ownership at scale. The Chief Revenue Officer and VP Commercial Operations roles signal expectations for leaders who can build and run revenue engines in a regulated health environment. The VP Investor Relations seat implies a need for someone who can translate clinical outcomes and business metrics into the language of public markets. The two Senior Director clinical roles require fluency in evidence standards for diabetes prevention and the operational realities of delivering a digital therapeutic at population scale. This role sits at the intersection of behavioral data, clinical protocol, and product iteration.
Remote-first is not a perk at Omada; it is a structural requirement. Every role on the board carries the "Remote, USA" tag. The company's public emphasis on measurable health outcomes (A1c reduction, weight loss maintenance, engagement retention) adds a second filter: the research shows the company tracks more than $1,000 saved per member in year one, 90%+ customer satisfaction across cardiometabolic programs, and 25M+ coach-member exchanges, Omada Health's website's figures put the exchange count at.
The compensation data reinforces the pattern: a $154,000 floor on the board's median band and a $305,000 ceiling. The company's stated values ("fall in love with the problem," "determination," "authenticity and humility") appear in founder interviews; the roles themselves are the real rubric.
What Employees Say
Public employee feedback on Omada Health is surprisingly thin. The research for this guide contains no direct employee quotations, no internal survey results, no exit-interview summaries, and no attributed anecdotes from current or former staff.
That absence is itself a signal. The board shows 29 salaried roles with a median band of $224,000 — senior-level compensation. Without review data, candidates cannot distinguish between rapid scaling and turnover at the top.
The company's own communications emphasize clinical rigor (30 peer-reviewed publications, $216 million in revenue growing more than 50% year over year, gross margins near 60%) and a "between-visit care" model that pairs human coaches with connected devices. The founder has described the mission as bending the curve of chronic disease for 156 million American adults. Those are business metrics, not employee experience metrics. They indicate a high-stakes, regulated-environment workplace where clinical outcomes, payer contracts, and compliance programs shape daily priorities.
Remote-first structure, confirmed by the job board's "Remote, USA" designation on every listed role, adds another dimension. The research contains no employee accounts to confirm or refute patterns of autonomy or cross-functional friction at Omada specifically.
Candidates should treat the review vacuum as a due-diligence item. In the absence of public data, the most reliable signals come from direct conversations: ask hiring managers about recent team attrition, request introductions to prospective peers, and probe how clinical quality reviews, product retrospectives, and payer escalations are actually run. The company's published values, those same principles, are aspirational; only current employees can say whether they translate into daily decision-making.
Who Thrives, Who Burns Out
Omada's remote-first, outcomes-obsessed model creates a sharp filter. The roles on Zero G Talent's board (all remote, all senior) reflect a company hiring for ownership. The headline metrics (the first-year savings of over $1,000 per member, nine in ten members satisfied across cardiometabolic programs, 25 million coach-member exchanges) are the operating levers the organization builds around.
The message volume shapes the care-team layer: 25M+ exchanges between coaches, nurses, and members means asynchronous, high-touch communication that runs continuously. The hiring bar selects for the blend of model performance and clinical validity: this role sits beside Senior Directors of Clinical Quality and Translational Research.
Burnout risk clusters around two profiles suggested by the structure. First, operators who mistake the remote-first label for flexibility without structure. Nearly 1,900 enrolled organizations each bring their own benefits design, eligibility rules, and reporting cadences; the VP of Commercial Operations and the CRO own those relationships end-to-end. That scope creates calendar density that doesn't compress because no one commutes.
Second, mission-driven clinicians or researchers who underestimate the commercial velocity. The same board shows a VP of Investor Relations and Capital Markets hired alongside clinical leadership; board-level fundraising and payer-contracting timelines move on a different clock than peer-review cycles.
The tension appears in the company's own framing: "Omada" derives from the Greek word for team (per the TP-Link Omada networking brand; Omada Health's site does not reference this etymology), yet the model demands individual accountability at the edges of a distributed system. It contains no employee accounts describing the culture as "high trust, high visibility" or citing "making calls in the dark" or "the pace of commercial asks outrunning clinical validation." Those complaints are not documented for Omada specifically. What is documented: the metrics are public, the care model is message-dense, and the remote structure means no one taps you on the shoulder to re-prioritize.
Working in frontier tech? Zero G Talent tracks the openings: see every open Omada Health role, browse frontier tech jobs, the companies hiring, and the people building the field.